Ülo Langel - Professor Emeritus, Stockholm University and Tartu University

Item: Ülo Langel - Professor Emeritus, Stockholm University and Tartu University
Rating: 4
Author: PostSingularity Institute

by Ülo Langel

Life & Natural Systems Medicine & Health MMedicine and Nursing MKGPharmacology

🎙 Ülo Langel 👥 1K 📅 March 9, 2026 ⏱ 31 min 👁 29 📄 expert opinion 🧭 2026-08-16

Available in: English (current) Français

Keywords

cell-penetrating peptidesdrug deliverypeptide nucleic acidstransportanpepFect

Summary

Ülo Langel, Professor Emeritus at Stockholm and Tartu Universities, presents a retrospective of his career in biochemistry, focusing on the development of cell-penetrating peptides (CPPs) for drug delivery. He begins by acknowledging the organizers and the collaborative effort behind the conference. He recounts his early days at Tartu University, where he was introduced to biochemistry through basketball, and his subsequent work on cholinesterase kinetics, which taught him the importance of scientific enthusiasm and the fallibility of scientific conclusions. Moving to Stockholm, he worked on galanin and neuropeptide receptors, leading to the synthesis of chimeric peptides with high affinity. This work evolved into the discovery of CPPs, starting with transportan, a peptide derived from galanin and mastoparan, which could penetrate cell membranes and carry cargo. He highlights the development of PepFect and NickFect peptides, which form nanoparticles with oligonucleotides for efficient delivery. He mentions the first in vivo applications, such as silencing galanin receptors for pain modulation, and the approval of a botulinum toxin-CPP conjugate for cosmetic use. He also introduces his company, Glaspher, which aims to develop CPP-based delivery systems for various nucleotides, targeting diseases like Alzheimer’s. The talk concludes with a Q&A session where he discusses the company’s focus and the potential of their technology.

206 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into the history and development of cell-penetrating peptides, a significant area in drug delivery. Langel’s personal narrative adds authenticity and highlights the collaborative nature of scientific research. However, the argumentation is largely anecdotal, with limited detailed evidence or references to specific studies. While he mentions several key discoveries and applications, the lack of in-depth mechanistic explanations or quantitative data weakens the scientific rigor. The talk is more of an overview and personal reflection than a critical analysis of the field.

Scientific Rigor, Source Quality, Title Accuracy

The talk is based on Langel’s extensive research experience, but he does not cite specific sources or provide references to publications. He mentions books he has authored, but no URLs are given. The title accurately reflects the content, as it is a lecture by Langel about his career. The scientific rigor is moderate; while the speaker is credible, the lack of citations and the informal nature of the presentation limit its reliability as a scientific source.

176 words

Title / Content Match

The title accurately reflects the content, which is a lecture by Ülo Langel about his career and research.

Quality & Reliability

7/10

The speaker is a professor emeritus with extensive research experience, but the talk is a personal retrospective without detailed citations or peer-reviewed references. Claims are plausible but not fully verifiable from the video alone.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

Books by Ülo Langel on Cell-Penetrating Peptides — Mentioned as available on the web, but no specific URLs provided.

Concurring Sources

Cell-penetrating peptides: from basic research to clinics — Review article on CPPs that aligns with the talk's content.

Dissenting Sources

Potential toxicity of cell-penetrating peptides — Some studies highlight toxicity concerns, which are not addressed in the talk.

Contribution & Novelties

The talk provides a personal account of the development of cell-penetrating peptides, highlighting key milestones and the evolution of the field. It offers insights into the challenges and successes of translating basic research into potential therapeutic applications. The speaker’s perspective as a pioneer adds unique value.

Pour aller plus loin :

Cell-penetrating peptide — Overview of CPPs and their mechanisms.
Peptide nucleic acid — Background on PNA, a key cargo molecule.
Transportan — Specific CPP mentioned in the talk.
PepFect — Another CPP family developed by the speaker.
Galanin receptor — Receptor targeted in early work.

96 words

Radar Profile

The radar profile shows moderate scores across all dimensions, with slightly higher scores in information quantity and quality, reflecting the speaker's expertise but limited depth. The low technical level suggests the talk is accessible to a broad audience.

Reliability 6/10

💬 No comments were provided for analysis.